By SUSAN HAIGH and MARC LEVY States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There's also some evidence that if Medicaid patients lose weight with the drugs, they'll be ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some evidence that if Medicaid patients lose weight with the drugs ...

The Skyrocketing Cost of Weight-Loss Drugs Has State Medicaid Programs Looking for a Solution States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There's also some evidence that if Medicaid patients lose weight with the drugs, they'll be ...